Remembering Emil von Behring: from Tetanus Treatment to Antibody Cooperation with Phagocytes

ABSTRACT A century ago, Emil von Behring passed away. He was the first to be honored by the Nobel Prize for Medicine in 1901 for the successful therapy of diphtheria and tetanus, which he had developed from the bench to the bed. He also contributed to the foundation of immunology, since his therapy...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autor principal:	Stefan H. E. Kaufmann
Formato:	article
Lenguaje:	EN
Publicado:	American Society for Microbiology 2017
Materias:	Microbiology QR1-502
Acceso en línea:	https://doaj.org/article/cfc7f6cd8031410a91718f6830645526
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:cfc7f6cd8031410a91718f6830645526
record_format	dspace
spelling	oai:doaj.org-article:cfc7f6cd8031410a91718f68306455262021-11-15T15:51:08ZRemembering Emil von Behring: from Tetanus Treatment to Antibody Cooperation with Phagocytes10.1128/mBio.00117-172150-7511https://doaj.org/article/cfc7f6cd8031410a91718f68306455262017-03-01T00:00:00Zhttps://journals.asm.org/doi/10.1128/mBio.00117-17https://doaj.org/toc/2150-7511ABSTRACT A century ago, Emil von Behring passed away. He was the first to be honored by the Nobel Prize for Medicine in 1901 for the successful therapy of diphtheria and tetanus, which he had developed from the bench to the bed. He also contributed to the foundation of immunology, since his therapy was based on passive immunization with specific antisera. Being an ambitious character, he did not shy away from friction with his colleagues Paul Ehrlich and Elias Metchnikoff and his mentor, Robert Koch. Behring was not only an excellent translational researcher but also a successful entrepreneur and early proponent of public-private partnerships.Stefan H. E. KaufmannAmerican Society for MicrobiologyarticleMicrobiologyQR1-502ENmBio, Vol 8, Iss 1 (2017)
institution	DOAJ
collection	DOAJ
language	EN
topic	Microbiology QR1-502
spellingShingle	Microbiology QR1-502 Stefan H. E. Kaufmann Remembering Emil von Behring: from Tetanus Treatment to Antibody Cooperation with Phagocytes
description	ABSTRACT A century ago, Emil von Behring passed away. He was the first to be honored by the Nobel Prize for Medicine in 1901 for the successful therapy of diphtheria and tetanus, which he had developed from the bench to the bed. He also contributed to the foundation of immunology, since his therapy was based on passive immunization with specific antisera. Being an ambitious character, he did not shy away from friction with his colleagues Paul Ehrlich and Elias Metchnikoff and his mentor, Robert Koch. Behring was not only an excellent translational researcher but also a successful entrepreneur and early proponent of public-private partnerships.
format	article
author	Stefan H. E. Kaufmann
author_facet	Stefan H. E. Kaufmann
author_sort	Stefan H. E. Kaufmann
title	Remembering Emil von Behring: from Tetanus Treatment to Antibody Cooperation with Phagocytes
title_short	Remembering Emil von Behring: from Tetanus Treatment to Antibody Cooperation with Phagocytes
title_full	Remembering Emil von Behring: from Tetanus Treatment to Antibody Cooperation with Phagocytes
title_fullStr	Remembering Emil von Behring: from Tetanus Treatment to Antibody Cooperation with Phagocytes
title_full_unstemmed	Remembering Emil von Behring: from Tetanus Treatment to Antibody Cooperation with Phagocytes
title_sort	remembering emil von behring: from tetanus treatment to antibody cooperation with phagocytes
publisher	American Society for Microbiology
publishDate	2017
url	https://doaj.org/article/cfc7f6cd8031410a91718f6830645526
work_keys_str_mv	AT stefanhekaufmann rememberingemilvonbehringfromtetanustreatmenttoantibodycooperationwithphagocytes
_version_	1718427426684403712

Remembering Emil von Behring: from Tetanus Treatment to Antibody Cooperation with Phagocytes

Ejemplares similares